Oorsprong van het eerstegraads netwerk van Wen Ge Zhong
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
QILU Regor Therapeutics, Inc.
3
| Private Company | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wen Ge Zhong via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Regor Therapeutics Group
 Regor Therapeutics Group Miscellaneous Commercial ServicesCommercial Services Regor Therapeutics Group is a biotech company founded in 2018 by a team of scientists with expertise in drug discovery and development. The company is based in Boston, MA and has subsidiaries in China. Regor Therapeutics Group utilizes its industry-leading core strength in Rcard™ to accelerate the discovery of innovative therapeutic agents. The company has completed 8 PCCs in-house, with 5 INDs filed, and has a pipeline of leading assets in metabolism, oncology, and auto-immunity. The company's two leading assets are RGT-075, an orally bioavailable small molecule GLP1R full agonist with potential for obesity and beyond, and RGT-419B, a unique CDK4+ inhibitor showing outstanding single agent responses in refractory ER+/HER2- breast cancer patients. The company was founded in 2018, and the CEO is Xiayang Qiu. | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer |
Statistieken
Internationaal
| Verenigde Staten | 2 |
Sectoraal
| Commercial Services | 2 |
Operationeel
| Founder | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Xiayang Qiu | 2 |
| Min Zhong | 2 |
| Xiao Tian Zhu | 1 |
- Beurs
- Insiders
- Wen Ge Zhong
- Bedrijfsconnecties
